{"nctId":"NCT00345969","briefTitle":"Exercise and Testosterone Therapy in Elderly Men With Physical Frailty","startDateStruct":{"date":"2004-11"},"conditions":["Physical Frailty","Hip Fracture","Elective Hip Replacement","Hypogonadism"],"count":25,"armGroups":[{"label":"Transdermal Testosterone gel (1%)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Transdermal Testosterone gel (1%)","Behavioral: Supervised exercise training"]},{"label":"Placebo gel","type":"PLACEBO_COMPARATOR","interventionNames":["Behavioral: Supervised exercise training"]}],"interventions":[{"name":"Transdermal Testosterone gel (1%)","otherNames":["Androgel"]},{"name":"Supervised exercise training","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male, age 65 years and older\n* Total serum testosterone level \\< 350 ng/dl\n* Total Modified Physical Performance Test Score \\<28\n\nExclusion Criteria:\n\n* Inability to walk 50 feet independently\n* Current use of estrogen, progestin, or androgen containing compound\n* Diagnosis of dementia of severity sufficient to interfere with informed consent or compliance with the protocol, or a score of 11 or greater on the Short Blessed Test of Orientation, Memory and Concentration\n* Visual or hearing impairments that interfere with following directions\n* Cardiopulmonary disease (recent MI, unstable angina or CHF, etc.), neuromuscular impairments, or unstable medical condition that would contraindicate progressive resistance exercise training\n* History of prostate cancer or hormone dependent neoplasia\n* PSA level \\> 4 ng/ml\n* Serum liver transaminase levels of greater than 2 standard deviations above normal\n* Use of drugs for osteoporosis for less than 1 year\n* Current participation in a vigorous exercise or weight-training program more than once per week\n* History of sleep apnea requiring use of CPAP\n* Uncontrolled thyroid disease\n* Diagnosis of cancer within the past 5 years other than superficial skin cancer (squamous or basal cell)\n* hematocrit \\> 50%\n* AUA symptom score \\> 16.\n* History of alcohol or substance abuse\n* Presence of severe facial acne\n* Active symptoms of depression with GDS score \\> 5 and symptoms severe enough to cause \\>5% weight loss in previous 3 months or interfere with research assessments","healthyVolunteers":false,"sex":"MALE","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change in Total Lean Body Mass","description":"Total Lean Mass measured by Dual X-ray Absorptiometry (DXA)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"1.8"},{"groupId":"OG001","value":"2.3","spread":"1.0"}]}]}]},{"type":"PRIMARY","title":"Change in Skeletal Muscle Strength by 1-RM","description":"One-repetition maximum strength for leg extension","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.2","spread":"33.3"},{"groupId":"OG001","value":"70.3","spread":"37.5"}]}]}]},{"type":"SECONDARY","title":"Change in Isokinetic Leg Extension Torque at 0 Deg/Sec","description":"Leg Extension Torque measured with Cybex dynamometer at 0 deg/sec","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.4","spread":"14.2"},{"groupId":"OG001","value":"19.8","spread":"18.1"}]}]}]},{"type":"SECONDARY","title":"Change in Leg Extension Torque at 60 Deg/Sec","description":"Leg Extension Torque measured with Cybex dynamometry at 60 deg/sec","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.7","spread":"13.5"},{"groupId":"OG001","value":"19.4","spread":"21.4"}]}]}]},{"type":"SECONDARY","title":"Change in Total Body Fat Mass","description":"Total Body Fat Mass as measured by DXA","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.96"},{"groupId":"OG001","value":"-1.1","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Change in Femoral Bone Mineral Density (BMD)","description":"Femoral Bone Mineral Density measured with Dual X-ray Absorptiometry (DXA)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.008","spread":"1.238"},{"groupId":"OG001","value":"0.084","spread":"3.515"}]}]}]},{"type":"SECONDARY","title":"Change in Total Modified Physical Performance (mPPT) Score","description":"The Modified Physical Performance Test (mPPT) is a direct observational test that assesses multiple dimensions of physical function (basic and complex activities of daily living \\[ADL\\]) with different levels of difficulty. The test consists of 9 performance tasks. The total score range is 0-36 (min-max), with higher scores indicating better performance. Sub-scores are assigned for each of 9 item tasks; sub-score range is 0-4 (min-max) with higher scores indicating better performance. The sub-scores are summed to compute the total score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","spread":"3.7"},{"groupId":"OG001","value":"2.8","spread":"4.4"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Serum Prostate Specific Antigen (PSA) Level","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.27"},{"groupId":"OG001","value":"0.21","spread":"0.63"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Hematocrit","description":"Percentage of the volume of whole blood composed of Red Blood Cells","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.14","spread":"2.6"},{"groupId":"OG001","value":"2.5","spread":"4.8"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Serum Total Cholesterol Level","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.2","spread":"15.4"},{"groupId":"OG001","value":"-9.0","spread":"42.9"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Serum HDL Cholesterol Level","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.4","spread":"9.0"},{"groupId":"OG001","value":"1.7","spread":"7.8"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Serum LDL Cholesterol Level","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.6","spread":"15.3"},{"groupId":"OG001","value":"-1.6","spread":"39.0"}]}]}]},{"type":"SECONDARY","title":"Change in Serum Testosterone Level","description":"Total Serum Testosterone Level (ng/mL)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.3","spread":"72.6"},{"groupId":"OG001","value":"121.2","spread":"235.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["Elevated serum PSA level","Fall"]}}}